AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. JCR Pharmaceuticals Co.,Ltd.
  3. Financials
  4. Revenue growth (%)

JCR Pharmaceuticals Co.,Ltd.【JP:4552】

Market cap
¥90B
P/E ratio
52.9x
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndRevenue growth (%) YoY (%)
Mar 31, 2025-22.9-192.07%
Mar 31, 202424.8-175.77%
Mar 31, 2023-32.8-146.96%
Mar 31, 202269.8+226.12%
Mar 31, 202121.4+205.71%
Mar 31, 20207-43.82%
Mar 31, 201912.5-10.17%
Mar 31, 201813.9+273.85%
Mar 31, 20173.7+7.23%
Mar 31, 20163.5-52.73%
Mar 31, 20157.3-35.73%
Mar 31, 201411.4+16.58%
Mar 31, 20139.8

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)